SHL Telemedicine, today announced that it will rebrand its subsidiary PHTS Telemedizin, Germany’s leading provider of telemedical care programs
Tel Aviv/Zurich, 29 June 2009 – SHL Telemedicine Ltd. (SIX Swiss Exchange: SHLTN), a leading provider and developer of advanced personal telemedicine solutions, today announced that it will rebrand its subsidiary PHTS Telemedizin, Germany’s leading provider of telemedical care programs, as SHL Telemedizin. SHL Telemedizin will continue to offer its telemedicine services from its medical monitor centre in Dusseldorf. With a common, strong brand, SHL will press forward to further develop and promote the future of telemedicine.
“Telemedicine offers numerous possibilities, be it in the prevention or in the monitoring of chronic diseases,” explains Yariv Alroy, Co-CEO of SHL Telemedicine. “Over the past 21 years, we have developed from a pioneer in telemedicine to an established provider. We are convinced that it has the potential of becoming a component of standard medical care and people’s daily routine. Both the individual and the health care system will benefit from it.”
Today, the advantages of telemedicine programs for cardiovascular patients with chronic and acute conditions have already been proven by SHL in several studies. Patients with congestive heart failure, for example, have to be admitted to a hospital significantly less often and for shorter periods of time, unnecessary calls for emergency medical assistance are reduced, and patients feel more secure and regain quality of life. Moreover, health care costs decrease considerably.
About SHL Telemedicine
SHL Telemedicine Ltd. specializes in developing and marketing advanced personal telemedicine systems as well as providing comprehensive telemedicine solutions including medical call centers to individuals and to the healthcare community. As a leading provider of remote health services in cardiology and in other medical areas, SHL maintains business operations in Europe, mainly in Germanyand at its home market in Israel. In the US, certain SHL telemedicine products are distributed by Philips Healthcare. SHL is listed on the SIX Swiss Exchange (SHLTN, ISIN: IL0010855885, Security No.: 1128957). More information available at: www.shl-telemedicine.com.
For further information please contact:
• Erez Alroy, Co-CEO, Phone: +972 3561 22 12, [email protected]
• Assistant: Pauline Shavit, Phone: +972 3561 22 12, [email protected]
• Martin Meier-Pfister, IRF Communications, Phone: +41 43 244 81 40, [email protected]
Some of the information contained in this press release contains forward-looking statements. Readers are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those in the forward-looking statements as a result of various factors. SHL Telemedicine undertakes no obligation to publicly update or revise any forward-looking statements.
